A former shareholder this month sued NuVasive (NSDQ:NUVA) for about $660,000 the plaintiff claims he’s owed for payments related to a NuVasive acquisition.
Dr. Andrew Cappuccino, an orthopedic surgeon working out of Buffalo, N.Y., claimed that NuVasive owes him for a milestone payment tied to FDA approval for a spinal device developed by Cervitech, which NuVasive acquired in 2009.